These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35914789)

  • 1. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
    Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE
    J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
    Poizeau F; Triquet L; Dupuy A
    Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360
    [No Abstract]   [Full Text] [Related]  

  • 3. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series.
    Russo R; Cozzani E; Micalizzi C; Parodi A
    Acta Derm Venereol; 2022 May; 102():adv00711. PubMed ID: 35229165
    [No Abstract]   [Full Text] [Related]  

  • 4. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
    Temiz SA; Abdelmaksoud A; Dursun R; Vestita M
    Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629
    [No Abstract]   [Full Text] [Related]  

  • 5. Pernio after COVID-19 vaccination.
    Lopez S; Vakharia P; Vandergriff T; Freeman EE; Vasquez R
    Br J Dermatol; 2021 Aug; 185(2):445-447. PubMed ID: 33893637
    [No Abstract]   [Full Text] [Related]  

  • 6. Chilblain lesions after COVID-19 mRNA vaccine.
    Pileri A; Guglielmo A; Raone B; Patrizi A
    Br J Dermatol; 2021 Jul; 185(1):e3. PubMed ID: 33904168
    [No Abstract]   [Full Text] [Related]  

  • 7. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?
    Meara AS; Silkowski M; Quin K; Jarjour W
    J Rheumatol; 2021 Nov; 48(11):1754. PubMed ID: 34210829
    [No Abstract]   [Full Text] [Related]  

  • 9. Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report.
    Souaid K; Oulès B; Sohier P; Deschamps L; Aractingi S; Dupin N
    Acta Derm Venereol; 2021 Nov; 101(11):adv00589. PubMed ID: 34396420
    [No Abstract]   [Full Text] [Related]  

  • 10. Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines.
    Sun Q; Freeman EE
    JAMA Dermatol; 2022 Feb; 158(2):217-218. PubMed ID: 34935876
    [No Abstract]   [Full Text] [Related]  

  • 11. Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines-Reply.
    McCleskey PE; Lieberman A; Herrinton LJ
    JAMA Dermatol; 2022 Feb; 158(2):218-219. PubMed ID: 34935853
    [No Abstract]   [Full Text] [Related]  

  • 12. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facial nerve palsy after COVID-19 vaccination - A rare association or a coincidence.
    Ish S; Ish P
    Indian J Ophthalmol; 2021 Sep; 69(9):2550-2552. PubMed ID: 34427272
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
    Bessis D; Trouillet-Assant S; Secco LP; Bardin N; Blanc B; Blatière V; Chable-Bessia C; Delfour C; Girard C; Richard JC; Gros N; Le Moing V; Molinari N; Pallure V; Pisoni A; Raison-Peyron N; Reynaud E; Schwob É; Pescarmona R; Samaran Q; Willems M; Vincent T; Sofonea MT; Belot A; Tuaillon É
    Br J Dermatol; 2022 Dec; 187(6):1032-1035. PubMed ID: 35971922
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on: Facial nerve palsy after COVID-19 vaccination - A rare association or coincidence.
    Gurnani B; Kaur K
    Indian J Ophthalmol; 2022 Jan; 70(1):348. PubMed ID: 34937292
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to comment on: Facial nerve palsy after COVID-19 vaccination - A rare association or coincidence.
    Ish S; Ish P
    Indian J Ophthalmol; 2022 Jan; 70(1):349. PubMed ID: 34937293
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 18. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
    Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19, COVID-19 Vaccinations, and Subsequent Abnormalities in the Retina: Causation or Coincidence?
    Jampol LM; Tauscher R; Schwarz HP
    JAMA Ophthalmol; 2021 Oct; 139(10):1135-1136. PubMed ID: 34473193
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermatology and COVID-19: Much knowledge to date but still a lot to discover.
    Le Cleach L
    Ann Dermatol Venereol; 2021 Jun; 148(2):69-70. PubMed ID: 33781568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.